In our previous study, Andrade et al. [50] showed that three CTAs (localized on the X chromosome) MAGE-C1/CT7, MAGE-A3/6, and LAGE-1 were often expressed in MM suggesting that they could be good candidates for immunotherapy. The gene discussed is MAGEC1; the disease is Miyoshi myopathy.